Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-K/A
Source: 0001731122-25-000252
Chunk: 183

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-K/A
Chunk 183
---
 |    121,859 |
| Segment operating loss                              |     | $    | 80,470,579 |     | $    | 1,168,717 |     | $     | 81,639,296 |

Geographic information:

RENB and RENC are managed on a worldwide basis but operate in offices located
in the United Stated and the Netherlands, respectively. The geographic information analyses the Company's operations and assets based
on the country in which each segment operates. In presenting this geographic information, segment operating results have been based on
the geographic location in which the services were provided to the segment and segment assets were based on the geographic location of
the assets.

NOTE 15 — SUBSEQUENT EVENTS

Related to the June 14, 2024, Private Placement, ranging from July 3, 2024, to
October 2, 2024, the Company sold 1,525,316 Units at a price per Unit equal to $1.4726 to a certain investor who paid in cash an aggregate
amount of $2,246,181 in consideration of the Units.

On August
1, 2024, the Company issued 2,000,000 shares of common stock for consulting services valued at $1,400,000.

On August 23, 2024, the Company
forfeited 833,333 shares of Common Stock from the original 1,000,000 shares of Common Stock for advisory services granted to Avram Miller,
a member of the Company’s board of directors on October 11, 2023. As consideration for and subject to such forfeiture, the Company
granted to Mr. Miller, an option to purchase 978,261 shares of Common Stock of the Company with a per-share exercise price equal to the
fair market value of a share of the Common Stock on the date thereof, $0.69.

<div align='center'>F-40</div>

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Not applicable.

Item 9A. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our Principal Executive Officer
and Principal Financial Officer (the “Certifying Officers”) are responsible for establishing and maintaining disclosure controls
and procedures for the Company. The Certifying Officers have designed such disclosure controls and procedures to ensure that material
information is made known to the Certifying Officers, particularly during the period in which this Report was prepared.

The Cert